Buscar
Mostrando ítems 31-40 de 779
Modeling Vaccine Preventable Vector-borne Infectations: Yellow Fever As A Case Study
(World Scientific Publ CO PTE LTDSingapore, 2016)
From a pathogen’s genome to an effective vaccine: The four-component meningococcal serogroup b vaccine Del genoma de un patógeno a una vacuna efectiva: La vacuna de cuatro componentes frente a los meningococos del serogrupo b
(Sociedad Espanola de Quiminoterapia, 2019)
© 2019, Sociedad Espanola de Quiminoterapia. All rights reserved.Invasive meningococcal disease (IMD), caused by the bacterium Neisseria meningitidis, entails significant mortality and morbidity. Disease incidence is highest ...
Technological roadmap in COVID-19 vaccine production
(Fiocruz/Instituto de Tecnologia em Imunobiológicos, 2022)
Modeling the public health impact of different meningococcal vaccination strategies with 4CMenB and MenACWY versus the current toddler MenACWY national immunization program in Chile
(Taylor & Francis Inc, 2021)
Invasive meningococcal disease (IMD) is an uncommon yet unpredictable, severe, and life-threatening
disease with the highest burden in young children. In Chile, most IMD is caused by meningococcal
serogroup B (MenB) and ...
Effectiveness of Meningococcal C conjugate vaccine in Salvador, Brazil: a case-control study.
(Public Library of Science, 2015-04)
Lymphocyte subset analyses in healthy adults vaccinated with yellow fever 17DD virus
(Fundação Oswaldo Cruz. Instituto Oswaldo Cruz., 2019)
Chagas disease vaccine design: the search for an efficient Trypanosoma cruzi immune-mediated control
(Elsevier Science, 2020-05)
Chagas disease is currently endemic to 21 Latin-American countries and has also become a global concern because of globalization and mass migration of chronically infected individuals. Prophylactic and therapeutic vaccination ...